A citation-based method for searching scientific literature

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
Times Cited: 930



Immune system to brain signaling: neuropsychopharmacological implications.
Lucile Capuron, Andrew H Miller. Pharmacol Ther 2011
Times Cited: 650




List of shared articles



Times cited

Integrating the monoamine and cytokine hypotheses of depression: Is histamine the missing link?
Melinda Hersey, Parastoo Hashemi, Lawrence P Reagan. Eur J Neurosci 2022
3

C-Reactive Protein as a Biomarker for Major Depressive Disorder?
Laura Orsolini, Simone Pompili, Silvia Tempia Valenta, Virginio Salvi, Umberto Volpe. Int J Mol Sci 2022
0

Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?
Grace A Porter, Jason C O'Connor. World J Psychiatry 2022
1

Sick for science: experimental endotoxemia as a translational tool to develop and test new therapies for inflammation-associated depression.
Julie Lasselin, Mats Lekander, Sven Benson, Manfred Schedlowski, Harald Engler. Mol Psychiatry 2021
20

Dendritic Cells: Neglected Modulators of Peripheral Immune Responses and Neuroinflammation in Mood Disorders?
Rafael Leite Dantas, Jana Freff, Oliver Ambrée, Eva C Beins, Andreas J Forstner, Udo Dannlowski, Bernhard T Baune, Stefanie Scheu, Judith Alferink. Cells 2021
3

Hippocampal Glycerol-3-Phosphate Acyltransferases 4 and BDNF in the Progress of Obesity-Induced Depression.
Yin-Qiong Huang, Yaofeng Wang, Keyue Hu, Shu Lin, Xia-Hong Lin. Front Endocrinol (Lausanne) 2021
3


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy